Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03926143
Title A Clinical Study of Anetumab Ravtansine in Adults With Solid Tumors Who Have Been Treated in Previous Bayer-sponsored Anetumab Ravtansine Studies
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors Bayer
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | POL | ITA | FRA

Facility Status City State Zip Country Details
University of Chicago Chicago Illinois 60637 United States Details
National Cancer Institute - Maryland Bethesda Maryland 20892 United States Details
Sarah Cannon Cancer Center Nashville Tennessee 37203 United States Details
Mary Crowley Medical Research Center Dallas Texas 75230 United States Details
Hôpital de la Timone - Marseille Marseille 13385 France Details
ASST Grande Ospedale Metropolitano Niguarda Milano Lombardia 20162 Italy Details
Samodzielny Publiczny Wojewodzki Szpital Zespolony Szczecin-Zdunowo 70-891 Poland Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field